XWELL, Inc. Share Price

XWEL

US98420U8027

Personal Services

Market Closed - Nasdaq 02:00:00 05/09/2026 am IST			5-day change	1st Jan Change
0.9756 ^USD	+0.57%		-3.41%	+111.72%

15/08	XWELL, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05/08	XWELL, Inc. Announces Board and Committee Changes, Effective August 8, 2026	CI

Last Transcript : XWELL, Inc.

XWELL, Inc., Q2 2025 Earnings Call, Aug 14, 2025

15/25/15

More transcripts

Analysts' recommendations : XWELL, Inc.

04/23/04	HC Wainwright Trims XWELL's Price Target to $1 From $1.50, Keeps Buy Rating	MT
16/22/16	HC Wainwright Adjusts Price Target on XWELL to $1.50 From $2, Maintains Buy Rating	MT
18/22/18	HC Wainwright Adjusts Price Target on XpresSpa Group to $2 From $4, Reiterates Buy Rating	MT
17/21/17	HC Wainwright Adjusts Price Target on XpresSpa Group to $4 From $3.50, Reiterates Buy Rating	MT
16/21/16	XpresSpa : HC Wainwright Starts XpresSpa Group at Buy With $3.50 Price Target	MT

More recommendations

News in other languages : XWELL, Inc.

30/20/30

Morning Briefing - International

More news

Managers and Directors : XWELL, Inc.

Manager	Title	Age	Since
Ezra Ernst CEO	Chief Executive Officer	57	04/09/2024
Thomas Brown DFI	Director of Finance/CFO	57	06/01/2025
Patti Ward COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Bruce Bernstein CHM	Chairman	62	01/02/2018
Robert Weinstein BRD	Director/Board Member	66	03/02/2020
Michael Lebowitz BRD	Director/Board Member	54	07/04/2020

More insiders

XWELL, Inc. is a global wellness company. The Company delivers restorative and health-focused services to travelers through its three operating segments: XpresSpa, XpresTest, and Naples Wax Center. XpresSpa operates spa service locations in major airports, offering massage, skincare, and travel products. The XpresTest segment provides aircraft wastewater and passenger nasal sampling through the Centers for Disease Control and Prevention's (CDC's) bio-surveillance program. The Naples Wax Center segment operates six locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products. Its health wellness beauty services include massage, waxing, facials, stretch, light emitting diode (LED) light therapy, meditation, manicures, pedicures, aromatherapy, anti-aging treatments, compression therapy, and massage chairs. Its subsidiaries include Naples Wax FRM LLC, Quantum Stream Inc., XpresSpa Holdings, LLC, XpresTest, Inc., and others.

Employees

228

Sector

Personal Services

More about the company

Quotes

Date	Price	Change	Volume
04/26/04	$0.9756	+0.57%	16,438
03/26/03	$0.9700	+0.42%	18,752
02/26/02	$0.9659	+1.67%	13,678
01/26/01	$0.9500	+4.09%	20,091
31/26/31	$0.9127	-9.63%	76,790

Delayed Quote Nasdaq

More quotes

Market Cap	83.79L 72.11L 67.84L 61.97L 1.16Cr 79Cr 1.16Cr 8.02Cr 3.11Cr 41Cr 3.15Cr 3.08Cr 130.77Cr	P/E 2024	-0.41x	P/E 2025	-0.09x
Enterprise Value	1.82Cr 1.57Cr 1.48Cr 1.35Cr 2.52Cr 172.24Cr 2.53Cr 17Cr 6.77Cr 88Cr 6.85Cr 6.7Cr 284.69Cr	EV / Sales 2024	0.2x	EV / Sales 2025	0.43x
Free-Float	75.8%	Yield 2024 *	-	Yield 2025	-

15/08	XWELL, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05/08	XWELL, Inc. Announces Board and Committee Changes, Effective August 8, 2026	CI
07/07	Xwell Agrees to Sell XpresSpa, XpresTest Businesses for $13 Million	MT
07/07	Face Haus, LLC entered into a definitive agreement to acquire Xprestest Inc. and XpresSpa Holdings, LLC from XWELL, Inc. for $13 million.	CI
21/05	XWELL, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02/04	Xwell registers resale of up to 138.7 million shares of common stock from time to time by selling stockholders - SEC filing	RE
01/04	XWELL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
25/02	Xwell announces approximately $31.3 million private placement priced at the market under Nasdaq rules	RE
24/02	XWELL, Inc. announced that it expects to receive $31.333 million in funding	CI
03/02	XWELL Inc. and PieQ Advance AI-Powered Biosecurity Forecasting Following CDC Milestone	CI
09/01	Xwell, Inc. Appoints Cindy Friedman as Senior Advisor	CI
18/12	XWELL Expands Beyond Airports with New Wellness Retail Location in New York City's Pennsylvania Station	CI
15/11	Wellness services firm XWELL's Q3 operating loss narrows	RE

05/08	XWELL Appoints Global Energy and Capital Markets Leader Gerard Reid to its Board of Directors	AQ
07/07	XWELL Announces Definitive Agreement to Divest XpresSpa and XpresTest Businesses	AQ
02/04	XWELL Reports Fiscal 2025 Results	AQ
27/02	Nasdaq Small-Caps: SNYR, XWEL, FGL, FMFC, Surge Into 2026 Spotlight	AQ
25/02	XWELL : Announces Approximately $31.3 Million Private Placement Priced At The Market Under Nasdaq Rules	PU

1 day	+0.57%
1 week	-3.41%
Current month	+6.89%
1 month	-2.44%
3 months	-28.26%
6 months	-32.72%
Current year	+111.72%

1 week	0.91	1
1 month	0.87	1.17
Current year	0.26	2.2
1 year	0.26	2.2
3 years	0.26	4
5 years	0.26	43.8
10 years	0.26	4,860

XWELL, Inc. Share Price

Stocks

XWEL

US98420U8027

Personal Services

Valuation : XWELL, Inc.

Chart: XWELL, Inc.

Latest news : XWELL, Inc.

Last Transcript : XWELL, Inc.

Analysts' recommendations : XWELL, Inc.

Press Releases : XWELL, Inc.

News in other languages : XWELL, Inc.

Quotes and Performance

Price Extremes

Managers and Directors : XWELL, Inc.

Latest insider transactions

Personal Care Services

Financials

Company Profile

Quotes

Date	Insider	Type	Main position	Quantity	% Market Cap.
25/08/26	Gaëlle Wizenberg	Free	Director	50,000	0.5921%
25/08/26	Michael Lebowitz	Free	Director	50,000	0.5921%
25/08/26	Robert Weinstein	Free	Director	50,000	0.5921%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
XWELL, INC.	+0.57%	-3.41%	-10.85%	-73.80%	83.79L
FAMEGLOW HOLDINGS LIMITED	-16.31%	+3.52%	+1,057.64%	+2,837.50%	245.43Cr
BEAUTY FARM MEDICAL AND HEALTH INDUSTRY INC.	-1.97%	-10.47%	-51.85%	+32.00%	55Cr
CONVANO INC.	-0.82%	+6.14%	-35.64%	+1,854.77%	39Cr
PERFECT MEDICAL HEALTH MANAGEMENT LIMITED	0.00%	0.00%	-16.56%	-66.50%	21Cr
SKINKANDY LIMITED	0.00%	+1.19%	-	-	21Cr
AB&COMPANY CO.,LTD.	-0.13%	-0.82%	+57.80%	+26.58%	14Cr
SIAM WELLNESS GROUP	-1.32%	-2.60%	-5.06%	-65.65%	12Cr
QB NET HOLDINGS CO.,LTD.	+0.31%	+0.38%	-0.46%	-19.71%	11Cr
REGIS CORPORATION	-1.04%	+5.07%	+17.91%	+38.35%	7.12Cr
Average	-2.07%	+0.16%	+112.55%	+507.06%	42.7Cr
Weighted average by Cap.	-9.75%	+1.32%	+629.53%	+1,893.54%

	2024	2025
Net sales	3.39Cr 2.92Cr 2.74Cr 2.51Cr 4.69Cr 320.04Cr 4.7Cr 32Cr 13Cr 164.2Cr 13Cr 12Cr 528.99Cr	2.92Cr 2.51Cr 2.36Cr 2.16Cr 4.04Cr 275.79Cr 4.05Cr 28Cr 11Cr 141.5Cr 11Cr 11Cr 455.84Cr
Net income	-1.69Cr -1.45Cr -1.36Cr -1.25Cr -2.33Cr -159.12Cr -2.34Cr -16Cr -6.26Cr -82Cr -6.33Cr -6.19Cr -263Cr	-1.7Cr -1.46Cr -1.38Cr -1.26Cr -2.35Cr -160.42Cr -2.36Cr -16Cr -6.31Cr -82Cr -6.38Cr -6.24Cr -265.16Cr
Net Debt	-10.3L -9L -8L -8L -14.25L -9.72Cr -14.29L -98.54L -38.24L -4.99Cr -38.68L -37.83L -16Cr	98.63L 84.87L 79.85L 72.94L 1.36Cr 93Cr 1.37Cr 9.44Cr 3.66Cr 48Cr 3.7Cr 3.62Cr 153.92Cr